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Ventral spinal cord interneurons
Cre recombinaseThe bHLH transcription factor Neurog1 (Ngn1, Neurod3, neurogenin 1) is involved in neuronal
differentiation and cell-type speciﬁcation in distinct regions of the developing nervous system. Here,
transgenic mouse models were developed that use a Bacterial Artiﬁcial Chromosome (BAC) containing
208 kb ﬂanking the Neurog1 gene to efﬁciently drive expression of GFP and Cre in all Neurog1 domains. Two
characteristics of Neurog1 gene regulation were uncovered. First, a 4 kb region previously shown to be
sufﬁcient for driving expression of a reporter gene to a subset of the Neurog1 pattern in the developing
midbrain, hindbrain, and spinal cord is required uniformly for high levels of expression in all Neurog1
domains, even those not originally identiﬁed as being regulated by this region. Second, a 0.8 kb enhancer was
identiﬁed that is sufﬁcient to drive Neurog1-like expression speciﬁcally in the ventral neural tube.
Furthermore, Neurog1 progenitor cells in the ventral neural tube are largely fated to interneuron lineages
rather than to motoneurons. These studies provide new tools for directing tissue speciﬁc expression in the
developing neural tube, deﬁne Neurog1 lineages in the spinal cord, and further deﬁne the complex genomic
structure required for obtaining the correct levels and spatial restriction of the neuronal differentiation gene
Neurog1.J.E. Johnson).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Proper neural function depends on development of the correct
number of cells with the correct identity for accurate assembly of
neuronal circuits. Neural basic helix-loop-helix (bHLH) transcription
factors are known regulators of neuronal differentiation and neuronal
sub-type speciﬁcation. A subset of neural-bHLH transcription factors,
including Neurog1, is transiently expressed in proliferating cells, and
expression is lost as these cells become postmitotic and differentiate
into more mature neural cell types (Cau et al., 2002; Fode et al., 2000;
Gowan et al., 2001; Lee, 1997; Ma et al., 1996; Schuurmans et al.,
2004). Overexpression studies have shown that Neurog1 is sufﬁcient
to induce neuronal differentiation inmouse embryonic carcinoma P19
cells, cortical progenitors in mouse, and neural tube in chick, Xenopus
and zebraﬁsh (Blader et al., 1997; Farah et al., 2000; Gowan et al.,
2001; Ma et al., 1996; Sun et al., 2001). Furthermore, Neurog1 has
been shown to play a role in specifying neuronal subtype in neural
crest derivatives where ectopic expression induced sensory neuron-
appropriate markers in non-sensory crest derivatives, and in chick
dorsal neural tube where Neurog1 induced excess dI2 dorsal
interneurons at the expense of neighboring dI1 and dI3 interneurons(Gowan et al., 2001; Perez et al., 1999). Loss-of-function studies in
mouse have shown that Neurog1 is required for the formation of
olfactory neurons and cranial sensory ganglia (Andermann et al.,
2002; Cau et al., 2002; Ma et al., 1998, 1999), and along with the
related factor Neurog2 (Ngn2, Math4A, neurogenin 2), is required for
the proper development of dorsal root ganglia, dorsal interneuron
population dI2 in the developing neural tube, and cerebral cortex
(Gowan et al., 2001; Kriks et al., 2005; Ma et al., 1999; Nieto et al.,
2001). Taken together these studies show that Neurog1 can induce
general neuronal differentiation and specify neuronal subtype in the
peripheral and central nervous systems. Hence, understanding how
Neurog1 expression is regulated during neurogenesis is an important
part of identifying the mechanisms involved in generating the correct
numbers and types of neurons necessary for the accurate assembly of
neuronal circuits.
Previous studies in mouse that tested regions of Neurog1 ﬂanking
sequence across a 15 kb region identiﬁed multiple intergenic regions
sufﬁcient to direct expression of reporter genes to a subset of the
Neurog1 expression domain (Blader et al., 2004; Gowan et al., 2001;
Murray et al., 2000; Nakada et al., 2004). However, these regulatory
regions were not sufﬁcient to recapitulate the entire Neurog1 pattern.
Here we use a modiﬁed Bacterial Artiﬁcial Chromosome (BAC) and
transgenic mice to demonstrate 208 kb ﬂanking the Neurog1 gene is
sufﬁcient to direct expression to all Neurog1 domains. For efﬁcient
levels of Neurog1-like expression, the BAC requires sequences that fall
Table 1
Mouse chromosome positions for transgenes.
Name Mousea chromosome position
(deleted regions in ΔR1, ΔR2, ΔR3)
Deletion or
transgene size (kb)
Neurog 1 codingb chr13: 56,352,559–56,353,294 0.735
N1457-nGFP chr13: 56,245,586–56,454,497 208
N1457-nGFPΔR1 chr13: 56,354,675–56,357,162 2.5
N1457-nGFPΔR2 chr13: 56,357,364–56,361,332 4.0
N1457-nGFPΔR3 chr13: 56,361,620–56,365,378 3.8
TgN1-16 chr13: 56,345,580–56,362,076 16.5
TgN1-2 chr13: 56,356,824–56,364,454 7.6
TgN1-13dnt chr13: 56,359,269–56,360,099 0.830
TgN1-15 chr13: 56,361,901–56,364,454 2.5
TgN1-15vnt chr13: 56,363,312–56,364,118 0.806
LATEc chr13: 56,359,328–56,359,715 0.387
ANPEc chr13: 56,360,975–56,361,111 0.136
LSEc chr13: 56,361,733–56,361,970 0.237
aMouse mm9 assembly from July 2007 used to determine locations.
bTranscribed in the reverse orientation.
cRegulatory regions conserved with D. rerio (Blader et al., 2003, 2004).
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multiple species including zebraﬁsh (Blader et al., 2004; Gowan et al.,
2001; Nakada et al., 2004). Even with the enhancer deleted, the BAC
retains activity for low levels of tissue speciﬁc expression suggesting
the presence of an autoregulatory element or a redundant secondary
enhancer at a distinct location. Furthermore, we identify a 0.8 kb
region that directs transgene expression speciﬁcally to the ventral
Neurog1 domain, identifying an enhancer that is distinct from the
previously deﬁned dorsal neural tube enhancer for Neurog1 (Nakada
et al., 2004), or the speciﬁc enhancers identiﬁed in zebraﬁsh (Blader
et al., 2004, 2003). Finally, we use the Neurog1 regulatory locus for in
vivo genetic fate mapping using a Cre-ﬂox system to demonstrate that
a majority of Neurog1 progenitors in the ventral neural tube are
preferentially fated to become ventral interneurons rather than
motoneurons.
Materials and methods
Targeted modiﬁcation of bacterial artiﬁcial chromosomes and generation
of transgenic mice
Neurog1457-nGFP and Neurog1457-Cre (herein called N1457-nGFP
and N1457-Cre) were developed using the RP23 457E22 BAC obtained
from BACPAC Resources Center (BPRC) at Children's Hospital Oakland
Research Institute in Oakland, CA. This BAC contains a genomic insert
of 208 kb with the Neurog1 coding sequence located centrally.
Homologous recombination in bacteria (Yang et al., 1997) was used
to replace the Neurog1 coding region precisely with coding sequence
for EGFP (Clontech) with a nuclear localization signal (Lumpkin et al.,
2003) or for Cre recombinase. TheN1457-nGFP BACwas further used to
delete the regions for N1457-nGFPΔR1, N1457-nGFPΔR2, and N1457-
nGFPΔR3 using BAC recombineering strategies (Lee et al., 2001). In
each case the targeting constructs for the BAC recombineering
contained 100–350 bp homology arms and deleted sequences from
2.5 to 4.0 kb (see Fig. 1 and Table 1). TgN1-16 was generated from
N1457-nGFP using the BAC retrieval method (Liu et al., 2003). TgN1-15Fig. 1. Diagram and summary of activity of Neurog1-GFP transgenes. Comparison of mouse a
13 reveals extensive conservation (shown 50–100%) in non-coding regions using ECR brow
blue is Neurog1 coding, yellow is UTR, and red is intergenic. Black blocks below the ECR dia
enhancers (LATE, ANPE, LSE) (Blader et al., 2004, 2003). The BAC transgene N1457-nGFP (m
indicated by brackets. The relative location of the deletions and the sequences tested in th
regions included in each. Precise coordinates in the genome are given in Table 1. Green bo
independent transgenic founder embryos at E11.5 that had detectable GFP and was examine
with the same transgene and representative images are shown in Figs. 2 and 4. Black +/- ind
The asterisks on TgN1-2 and TgN1-13dnt indicate they were reported in Nakada et al. (2004
ventral telencephalon (vt) expression rather than dorsal. vnt, ventral neural tube; dnt, dorandTgN1-15vntwere generated by cloning the regionof interest byPCR
into BgnGFP reporter cassette (Lumpkin et al., 2003). TgN1-15vntmgli is
TgN1-15vnt with two candidate gli consensus sites mutated. The
sequence TGGGTGTTCAGCCCCTGCTGGAAAAAGGCTCGGTGGGTGGG
with the possible gli sites underlined was mutated from TGGGT in
each case to GTATA. TgN1-2 and TgN1-13dnt have been described
previously (Nakada et al., 2004, TgN1-13). Table 1 lists the positions on
chromosome 13 for the transgene ends or deletion regions used in this
study (using the mouse mm9 assembly July 2007).
Transgenic mice were generated by pronuclear injection using
fertilized eggs from B6SJLF1 (C57BL/6J×SJL/J) crosses using standard
procedures (Hogan et al., 1986) in the UTSW Core Transgenic Facility.
Qiagen puriﬁed BAC DNA (two independent clones per BAC deletion)
was injected at 0.3–1 ng/μl in 10 mM Tris pH 7.5, 0.1 mM EDTA,
100 mM NaCl. Non-BAC transgenes were isolated from the vector
backbone and injected at 1–3 ng/µl in the injection buffer above
lacking the NaCl. Transgenic animals were identiﬁed by PCR usingnd human genomes surrounding the Neurog1 coding sequence on mouse chromosome
ser (Ovcharenko et al., 2004). Colors indicate over 70% conservation in sequence where
gram indicate sequence conserved to D. rerio that have been identiﬁed in functioning
odiﬁed BAC RP23 457E22) is shown with the location of deletions in ΔR1, ΔR2, ΔR3
e transgenes are diagramed below the ECR browser image to highlight the conserved
xes indicate the GFP reporter coding sequence. # Expressing indicates the number of
d for expression in the tissues listed. Expression pattern was consistent across embryos
icate similarity to wildtype while red +/- highlight expression different fromwildtype.
) and are shown here for comparison. ^ indicates these transgenes aberrantly directed
sal neural tube.
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CATGCC-3′; 5′-GTGAGCAAGGGCGAGGAGCTGTT-3′ or to Cre: 5′-
GGACATGTTCAGGGATCGCCAGGCG-3′; 5′-GCATAACCAGTGAAACAG-
CATTGCTG-3′. The N1457-nGFP transgenic strain was used in studies
of ear development as it marks Neurog1 expressing progenitors fated
to be neurons in the VIIIth cranial ganglion (Raft et al., 2007), in
studies of thalamus development (Vue et al., 2007), and it was
contributed to the GENSAT project for their standard expression
analysis (http://www.ncbi.nlm.nih.gov/projects/gensat/).
Cre reporter mouse strains R26RlacZ (Soriano, 1999), R26RYFP
(Srinivas et al., 2001), and Z/EG (Novak et al., 2000) were genotyped
by PCR using primers as previously published: for R26R; 5′-
AAAGTCGCTCTGAGTTGTTAT-3′; 5′-GCGAAGAGTTTGTCCTCAACC-3′;
5′-GGAGCGGGAGAAATGGATATG-3′; and for Z/EG: 5′-TTACTTGTA-
CAGCTCGTCCATGCC-3′; 5′-GTGAGCAAGGGCGAGGAGCTGTT-3′.
Tissue preparation and immunohistochemistry
E11.5 or E12.5 embryos were collected in Phosphate Buffer (PO4)
at 4 °C and imaged as whole embryos. Embryoswere then ﬁxed for 2 h
in 4% paraformaldehyde-PO4 (pH 7.2), washed overnight with PO4-
buffer, and sunk in 30% sucrose-PO4 all at 4 °C. Embryos were
embedded in OCT (Tissue Tek) and cryosectioned at 25 to 50 μm.
Neural tube sections are from the forelimb region.
Immunohistochemistry was performed by incubating with the
appropriate dilution of primary antibodies in PBS/1% goat serum/0.1%
Triton X-100, followed by incubationwith secondary antibodies goat–
anti-rabbit or goat–anti-mouse IgG, conjugated to Alexa Fluors 488,
594, or 647 (Molecular Probes, Inc.). Primary antibodies include:
mouse monoclonal antibodies anti-Ascl1 (Mash1) (1:100) (Lo et al.,
1991), anti-Islet1/2 (1:100, 39.4D5, DSHB), anti-Lhx1/5 (1:100, 4F2,
DSHB), and rabbit antibodies anti-Lhx2/9 (1:8000) (gift from
T. Jessell), anti-Neurog1 (Ngn1) (1:500) (Gowan et al., 2001), anti-
Atoh1 (Math1) (1:100) (Helms and Johnson, 1998), anti-Olig2
(1:1000, gift from C. Stiles and R. Lu), anti-Islet1/2 (1:500) (Tsuchida
et al., 1994), anti-GFP (1:500, Molecular Probes, A6455), anti-HB9
(1:500, Abcam), and anti-Cre (1:500, Sigma), and guinea pig anti-
Brn3a (1:250) (gift from E. Turner). Sections were imaged by confocal
using Bio-Rad MRC1024 or Zeiss LSM510.
For β-galactosidase detection, embryos were ﬁxed in 4% parafor-
maldehyde in PBS at room temperature for 30 min, washed with
PBS twice for 10 min at room temperature, and incubated overnight in
X-gal staining solution at 30 °C (1 mg/ml 5-bromo-4-chloro-3-indolyl-
β-D-galactopyranoside (X-gal), 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6,
5 mMMgCl2 in PBS). Stained embryos were rinsed in PBS and postﬁxed
in 4% paraformaldehyde 3–6 h at room temperature before preparing
for cryosection as described above.
Results
A 208 kb region surrounding Neurog1 contains sufﬁcient cis-regulatory
sequence for directing accurate Neurog1 expression
As no single regulatory region in the Neurog1 locus had been shown
to direct expression to all Neurog1 domains, we tested a large genomic
region using a modiﬁed BAC and transgenic mice. Using BAC
recombineering techniques (Yang et al., 1997), the Neurog1 coding
sequence, which is contained within one exon, was precisely replaced
with a nuclear localized EGFP in BAC RP23 457E22. This modiﬁed BAC
containing 101 kb 5′ and 107 kb 3′ genomic sequence ﬂanking the
Neurog1 coding region was injected into the pronuclei of single cell
mouse embryos. Transgenic embryos were harvested at E11.5 and
assayed for GFP expression. In N1457-nGFP transgenic embryos at E11.5,
GFP expression was detected in all Neurog1 domains including dorsal
and ventral neural tube (dnt and vnt), olfactory epithelium, cranial
sensory ganglia, midbrain, and hindbrain (Figs. 1 and 2A,A′B,B′).Notably, expression in the dorsal root ganglia (drg) and dorsal
telencephalon was also detected (Figs. 1 and 2B,B′,F), and represents
domains of Neurog1 expression where no cis-regulatory sequences had
been previously identiﬁed in mouse.
To determine if N1457-nGFP directs expression precisely to Neurog1
domains, we examined whether GFP respected the endogenous
boundaries of Neurog1 expression in the telencephalon and neural
tube. In the telencephalon, Neurog1 is restricted to dorsal regions
with its ventral boundary marked by the bHLH factor Ascl1 (Mash1)
(Ma et al., 1997). GFP from N1457-nGFPmimics this pattern and shares
the same ventral boundary (Fig. 2F). In the E11.5 neural tube, co-
expression of GFP with Neurog1 demonstrates expression from the
BAC is restricted to the Neurog1 domain in these regions as well
(Fig. 3A–D). In the dorsal neural tube, Neurog1 is present precisely in
progenitors to the dorsal interneuron population 2 (dI2), non-
overlapping with the closely neighboring progenitors marked by the
bHLH factors Ascl1 (Mash1) and Atoh1 (Math1) (Fig. 3 upper
diagram). We demonstrate that GFP overlaps with Neurog1
(Fig. 3E) but not Ascl1 or Atoh1 (Fig. 3F,G). Furthermore, GFP persists
into differentiating interneurons, and the GFP overlaps with the dI2
markers Lhx1/5 but not dI1 markers Lhx2/9, consistent with GFP
expression precisely in dI2 but not dI1 neurons (Fig. 3H,I). In the
ventral neural tube, the Neurog1 domain is bounded by Ascl1 dorsally
and Olig2 ventrally (Fig. 3 lower diagram). Likewise, GFP is present in
the ventral progenitor domain overlapping with Neurog1 (Fig. 3J) but
not with either Ascl1 or Olig2 (Fig. 3K,L). Although GFP is at lower
levels in Neurog1 cells closest to the ventricle, essentially all Neurog1
positive cells have detectable GFP. Again, since the GFP persists into
differentiating neurons, we detect extensive overlap with Lhx1/5 that
marks interneurons dI6, V0, V1 and V2, and Chox10 that alsomarks V2
(Fig. 3M,N). GFP positive cells are bounded by dI5 neurons marked by
Brn3a at the dorsal boundary (Fig. 3M) and motoneurons marked by
Isl1/2 at the ventral boundary (Fig. 3O). Overall, the BAC transgene,
N1457-nGFP, reliably reports Neurog1 expression domains at E11.5. A
stable transgenic strain with this BAC was contributed to the GENSAT
project and the standard GENSAT characterization at E15.5, P7 and
adult is available through that project at (http://www.ncbi.nlm.nih.
gov/projects/gensat/). This transgenic strain was also shown to
express in a Neurog1-like pattern in the VIIIth cranial ganglia (Raft et
al., 2007), developing thalamus (Vue et al., 2007), and olfactory
epithelium (data not shown).
Redundant regulatory information for tissue speciﬁc expression
The reliable expression of N1457-nGFP in transgenic mice provided
a tool to test whether the enhancer sequences previously described as
sufﬁcient for directing expression to speciﬁc subsets of the Neurog1
pattern are also required, a test rarely performed for identiﬁed
enhancers. Three deletions were made in the N1457-nGFP BAC using
homologous recombination in bacteria (Lee et al., 2001). Each
mutated BAC was used to generate transgenic embryos that were
assayed at E11.5. To control for unplanned, undetected rearrange-
ments in the BAC sequences, two independently derived BAC
constructs for each deletion were used to generate multiple
transgenic embryos. One deletion, N1457-nGFPΔR1, that deleted a
largely non-conserved genomic region, had no detectable alteration in
the expression of the reporter gene at E11.5 (Figs. 1 and 2C,C′). This is
consistent with early studies that showed this region worked only
inefﬁciently at directing expression of a reporter to Neurog1 domains
in transgenic mice (Murray et al., 2000; Nakada et al., 2004).
Two additional deletions were designed to test the requirement
for highly conserved sequences shown previously to direct expression
of reporter transgenes in a subset of the Neurog1 pattern in transgenic
mice (Gowan et al., 2001) (also see Figs. 1 and 4B, TgN1-2). The
deletion in N1457-nGFPΔR2 includes 4 kb of the 7.6 kb enhancer
(TgN1-2) shown previously to be sufﬁcient to drive reporter
Fig. 2. GFP expression from Neurog1-GFP BAC transgenic mice. mRNA in situ hybridization for Neurog1 in an E11.5 mouse embryo in whole mount (A) or in a cross section of the
neural tube (A′). (B–E) GFP expression in representative BAC transgenic embryos is shown in whole mount at E11.5. (B′–E′) cross sections show the Neurog1-like expression in the
dorsal neural tube (dnt), the ventral neural tube (vnt), and the dorsal root ganglia (drg). (B″,E″) show a higher magniﬁcation of the GFP expression in the vnt and drg from N1457-
nGFP compared to N1457-nGFPΔR3 to highlight the speciﬁc reduction in vnt activity with this deletion. (F,G) Telencephalon showing GFP relative to Ascl1 immunoﬂuorescence (red).
GFP from N1457-nGFP reﬂects the endogenous Neurog1 in the dorsal telencephalon while TgN1-15vnt has aberrant expression in the ventral telencephalon. Transgenes are diagramed
and results summarized in Fig. 1. dt, dorsal telencephalon; hb, hindbrain; mb, midbrain; oe, olfactory epithelium; tg, trigeminal ganglion.
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Nakada et al., 2004), and contains two highly conserved sequences,
LATE and ANPE, shown to be important in zebraﬁsh neurogenin 1
expression (Blader et al., 2004, 2003). This sequence also contains an
element speciﬁc for dorsal neural tube expression (TgN1-13dnt), but
lacks information sufﬁcient to direct expression to the dorsal root
ganglia and the dorsal telencephalon (Nakada et al., 2004) (also see
Figs. 1 and 4B,F). Thus, we predicted that N1457-nGFPΔR2 would lack
expression in multiple domains particularly the dorsal neural tube,
but expression in dorsal root ganglia and dorsal telencephalon would
be spared. Surprisingly, in N1457-nGFPΔR2 there was no speciﬁc loss of
activity in one tissue over another. Rather, there was a dramatic
decrease in overall reporter expression levels across all domainswhen
compared to N1457-nGFP (Figs. 1 and 2 compare B,B′ with D,D′).
Although signal ampliﬁcation was required to detect the GFP
consistently in all N1457-nGFPΔR2 embryos, expression in all Neurog1
domains was detected and the precise dI2 progenitor boundaries
were maintained (data not shown). This dramatic decrease in overall
expression demonstrates the presence of a general enhancer
component, or locus control region, within the sequence deleted.
This broad activity across all Neurog1 domains of the 4 kb sequence
was not detected previously since it is not sufﬁcient to direct
expression to all Neurog1 domains on its own. Furthermore, the fact
that low expression remains precisely in a Neurog1-like pattern
suggests either the existence of an inefﬁcient autoregulatory
enhancer, or a secondary redundant enhancer elsewhere within the
208 kb BAC. Secondary enhancers have been seen in multiple
developmental genes in Drosophila andmouse, andmay be a common
strategy to ensure reproducible expression of essential genes (Hong
et al., 2008; Jeong et al., 2006; Markstein et al., 2002; Zeitlinger et al.,
2007).A ventral neural tube speciﬁc enhancer is identiﬁed
In contrast to the phenotype in the ﬁrst two deletions, N1457-
nGFPΔR3 resulted in a dramatic loss of expression in a speciﬁc subset
of the Neurog1 pattern (Figs. 1 and 2E,E′). The region deleted in N1457-
nGFPΔR3 contains the other half of TgN1-2, sequence that includes the
LSE conserved region important for neurogenin 1 expression in
primary neurogenesis and telencephalon in zebraﬁsh (Blader et al.,
2003) (Fig. 1). With this deletion, there was a dramatic decrease in
GFP levels speciﬁcally in the ventral neural tube relative to the GFP
levels in the other Neurog1 domains. This is highlighted by comparing
the levels in the dorsal root ganglia to the levels in the ventral neural
tube in the wild type N1457-nGFP versus the N1457-nGFPΔR3
transgenic embryos (Fig. 2B′,B″,E′,E″). From these data, it is clear
that the sequence deleted is required for efﬁcient expression in the
ventral neural tube but not other domains. The low level expression
remaining in the ventral neural tube is consistent with the existence
of an autoregulatory component, or secondary enhancer as suggested
above with N1457-nGFPΔR2 (see previous section).
Analyzing ventral neural tube expression from additional trans-
genic constructs identiﬁed the location of the ventral neural tube
enhancer. First, a 16 kb sequence including 9 kb 5′ and 7 kb 3′ of
Neurog1 (including LATE, ANPE, and LSE conserved regions) was
retrieved from N1457-nGFP using recombination in bacteria (Liu et al.,
2003), and tested for activity in transgenic mice (TgN1-16). This
transgene was designed to test the most highly conserved sequence
from the locus that might reveal efﬁcient expression in such domains
as the dorsal root ganglia and telencephalon that had so far only been
seen with the 208 kb BAC. However, the 16 kb was not sufﬁcient to
recapitulate all Neurog1 domains. GFP expression from this construct
mimickedNeurog1 expression in the dorsal neural tube, a narrow strip
Fig. 3. N1457-nGFP directs GFP expression precisely to the Neurog1 lineage. (A,B) show a cross section through the neural tube of an E11.5N1457-nGFP embryo labeled by
immunoﬂuorescence for Neurog1 (A) or direct ﬂuorescence of GFP (B) and indicate GFP expression is restricted to Neurog1 domains in the dnt, vnt, and drg at this level. Arrows
indicate the dorsal and ventral boundaries of expression for Neurog1 and GFP match. (C,D) are high magniﬁcation of views of the dnt and vnt demonstrating the co-expression of
Neurog1 and GFP. (E–I) focuses on the dnt and compares GFP with immunoﬂuorescence for Neurog1, Ascl1, Atoh1, Lhx1/5 or Lhx2/9 from N1457-nGFP in E11.5 dnt. Overlap of the
GFP signal with Neurog1 (yellow) and Lhx1/5 (turquoise) but none of the other factors illustrates the precision with which the BAC transgene is controlling GFP expression. (J–O)
focuses on the vnt and compares GFPwith immunoﬂuorescence for Neurog1, Ascl1, Olig2, Lhx1/5, Brn3a, Chx10 and Isl1 from N1457-nGFP in E11.5 vnt. Dashed line indicates position
of the ventricular zone. Overlap of the GFP signal with Neurog1 (yellow), Lhx1/5 (turquoise), and Chox10 (yellow) but none of the other factors suggests the Neurog1 lineage in the
ventral neural tube comprises interneurons rather thanmotoneurons. Diagrams for progenitor/neuron relationships andmarkers are shown for both dnt and vnt. dI5 and dI6, dorsal
interneurons 5 and 6; MN, motoneuron; V0–V2, ventral interneurons.
287H.I. Quiñones et al. / Developmental Biology 340 (2010) 283–292in the ventral neural tube, trigeminal ganglia, and at least a subset of
the hindbrain and midbrain domains. Strikingly, expression in the
majority of the ventral neural tube, dorsal root ganglia, dorsal
telencephalon, and olfactory epithelium was lost (Figs. 1 and 4A).
This clearly places required enhancer sequences for these last four
domains outside the 16 kb tested. For the ventral neural tube,
comparing the 5′ end of TgN1-16 with the previously reported
TgN1-2 that does contain ventral neural tube enhancer activity
(Nakada et al., 2004), suggested the required information for at least
this domain was coded in a 2.5 kb region (Figs. 1 and 4B,B′). In
transgenic mice, we tested this 2.5 kb (TgN1-15) as well as a more
restricted 0.8 kb region (TgN1-15vnt) that contained the sequence
with the highest conservation between mammalian species. Both
transgenes were sufﬁcient to direct GFP expression to the ventral
neural tube from spinal regions to the hindbrain, the olfactory
epithelium, and a subset of the dorsal telencephalon, but not other
Neurog1 expression domains (Figs. 1 and 4C–D′). Unexpectedly GFP
was also detected in the telencephalon. A closer examination ofsections from these embryos revealed that this expression did not
mimic Neurog1 but rather was restricted to the ventral telencephalon
(Fig. 2, compare F and G). These later data suggest the presence of a
repressor sequence in the TgN1-2 that is not present in TgN1-15.
To characterize the expression pattern of the 0.8 kb vnt enhancer,
we used immunoﬂuorescence to delineate boundaries and overlap of
GFP with other markers. First we compared the GFP signal to
endogenous Neurog1 and found that the domains largely overlap
(Fig. 4Da). The exception is the most dorsal boundary of the ventral
Neurog1 domain where GFP is missing (Fig. 4Da, arrowhead). The
regulatory element for this subset of the Neurog1 pattern is likely
located at a distinct site within TgN1-16 (Fig. 4A′, arrowhead). The
ventral boundary of the GFP pattern abuts the Olig2 domain that
marks progenitors to motoneurons (Fig. 4Db,Dc), just as was
demonstrated for the N1457-GFP BAC transgenic embryos (Fig. 3L).
Thus, the 0.8 kb vnt enhancer directs expression to the ventral
Neurog1 domain except for a small subset of progenitors at the dorsal
boundary that likely give rise to the dI6 interneurons.
Fig. 4. An enhancer for Neurog1-like expression in the ventral neural tube is identiﬁed. (A–F) GFP expression in representative transgenic embryos is shown inwhole mount at E11.5.
(A′–F′) cross sections show the activity of each transgene in the neural tube. Transgenes are diagramed and results summarized in Fig. 1. Within the spinal neural tube, TgN1-2
directs expression to both dorsal neural tube (dnt) and ventral neural tube (vnt) whereas TgN1-16 and TgN1-13dnt are largely restricted to the dnt (A′, arrowhead indicates the
narrow strip of ventral neural tube expression consistently seen with TgN1-16), and TgN1-15 and TgN1-15vnt are restricted to the vnt. Activity for expression in dorsal root ganglia
(drg), dorsal telencephalon, olfactory epithelium (oe), trigeminal ganglion (tg), and subsets of hindbrain (hb) and midbrain (mb) is not present in every transgene. For example,
drg and dt are largely absent in all transgenes, whereas oe is only seen in TgN1-2, TgN1-15 (tail obscuring oe in this image), and TgN1-15vnt, and tg is only in TgN1-16 and TgN1-2.
(Da–Dc) immunoﬂuorescence on E11.5 cross sections of TgN1-15vnt neural tube. (Da) Dashed lines delineate the dorsoventral boundaries of the ventral Neurog1 (red) domain is
shared by GFP but also highlight the more dorsal part of this domain is lacking GFP (arrowhead). (Db) Arrows highlight the boundaries of non-overlap of GFP with Ascl1 (red) and
Olig2 (blue). (Dc) is a higher magniﬁcation of the progenitor domains for V2 interneurons and motoneurons (MN). In the pV2 region there are a few cells that co-express Ascl1 and
Neurog1 (Da) and GFP (Dc, arrowheads). Ventral telencephalon (vt) expression, non-Neurog1 pattern, appears in TgN1-15 and its derivatives (see Fig. 2G for a cross section).
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consensus binding sites (Vokes et al., 2007) in sequence conserved
across multiple mammalian species. Gli factors are transcription
factors downstream of Shh signaling. Since Shh is active in the
developing ventral neural tube, this possible direct connection of Shh
signaling to Neurog1 regulation through the vnt enhancer was an
attractive hypothesis to link patterning signals to this transcription
factor regulating differentiation. We mutated the two candidate gli
sites within the context of the TgN1-15vnt reporter and tested it in
transgenic embryos. Mutating the gli sites (TgN1-15vntmgli) did not
alter the pattern of GFP expression. However, as a group these
embryos had lower expression that required longer exposure times
to image the pattern (Fig. 4E,E′). These results suggest a possible role
for Shh signaling through gli for enhancer activity but not for the
pattern.
Neurog1 progenitor cells in the ventral neural tube preferentially give
rise to interneurons and a limited contribution to motoneurons
The transient expression of the Neurog1 gene and the relatively
fast degradation of its protein product makes it difﬁcult to determine
which neural cell types arise from Neurog1 expressing cells. Based on
its expression pattern in the neural tube, it has been inferred that
progenitors expressing this protein will largely give rise to ventral
interneurons andmotoneurons. To determine precisely which ventralneurons are in the Neurog1 lineage, we exploited the GFP stability in
the N1457-nGFP mice to perform short-term lineage tracing by co-
labeling with markers speciﬁc for various neuronal populations as
described above and shown in Fig. 3. Analysis of the N1457-nGFP
revealed that a majority of ventral interneurons are derived from
Neurog1 progenitors, with much less GFP detected in the motoneuron
domain (MN) (Fig. 3). Indeed, the lack of overlap with Olig2 in the
progenitor domain predicts exclusion of the Neurog1 lineage in the
motor pools since Olig2 progenitors are known to become motor
neurons (Mukouyama et al., 2006; Park et al., 2002; Zhou and
Anderson, 2002). However, since GFP from N1457-nGFP is transient it
is possible that the earlier formed MN populations lost their GFP by
E11.5. Examination of the embryos at E10.5 still did not reveal
extensive GFP in the MN population (data not shown).
To determine whether the Neurog1 progenitor cells do preferen-
tially give rise to ventral interneurons over motoneurons, we used in
vivo genetic fatemappingwith Cre recombinase.We generatedN1457-
Cremice with the same strategy used to generate the N1457-GFPmice.
Just as the GFP in the N1457-GFP mice, expression of Cre recombinase
in the N1457-Cre mice closely mimics the pattern of endogenous
Neurog1 (Fig. 5A–C). Immunoﬂuorescence detecting Cre in E11.5
embryos revealed the same pattern of expression as Neurog1
(compare Figs. 3A and 5B) including the dorsal root ganglia, and the
dorsal and ventral neural tubes. Embryos from N1457-Cre;R26RYFP or
N1457-Cre;R26RlacZ transgenic mice revealed a pattern of reporter gene
Fig. 5. In vivo analysis of the Neurog1 lineage in the neural tube using Cre recombinase. (A,C) E11.5 embryos from N1457-Cre crossed with Cre reporter strains are shown in whole
mount (A, R26RYFP; C, R26RlacZ), or cross section (C′). (B) Cre immunoﬂuorescence mimics the Neurog1 pattern in the neural tube at E11.5 (compare to Fig. 3A). (D) Spinal cord from a
30-day old N1457-Cre;R26RlacZ mouse showing the location of Neurog1-lineage neurons. (E–I) Cross sections through the neural tube of N1457-Cre;Z/EG E12.5 embryos. (E,E′) GFP
shows Neurog1 lineages where Cre activity has recombined the reporter and includes the drg, a minor dorsal population, and a major ventral population in the neural tube. (F,F′) X-gal
staining indicates non-Neurog1 lineages that lack Cre activity. The dashed area highlightsmotoneuron populations that aremostly not included in theNeurog1 lineages. (G) Extensive co-
expression of the GFP is detectedwith the broad interneuron (IN)marker Lhx1/5. (H,I) Co-expression withmotoneuron (MN)markers Hb9, Isl1/2, and Lhx3 is low. LMCm, lateral motor
column medial; LMCl, lateral motor column lateral; MMCm, medial motor column medial.
289H.I. Quiñones et al. / Developmental Biology 340 (2010) 283–292expression in the neural tube and the sensory ganglia consistent with
labeling of Neurog1 lineages at E11.5 (Fig. 5A,C,C′). A cross section
through the neural tube region of a β-gal stained embryo shows
expression in differentiated neurons (Fig. 5C′). By adult stages the
Neurog1 lineage cells are mature neurons that have settled in the
intermediate and ventral gray matter of the spinal cord (Fig. 5D).
We used the N1457-Cre mice with the Z/EG reporter line that
expresses GFP in cells where Cre recombinase is active, and expresses
LacZ in cells in the absence of recombination (Novak et al., 2000) to
assess the fate of theNeurog1 progenitors in the ventral neural tube. In
E12.5 neural tubes of N1457-Cre;Z/EG mice, GFP expression was
predominant in ventral interneuron domains, but was notably sparse
in motoneuron domains (Fig. 5E,E′). Indeed, the LacZ expression
pattern in this region was complementary to that of GFP, where LacZ
was found predominantly in the motoneuron domain (compare
Fig. 5E,E′ with F,F′). These results show that Neurog1 lineage cells
largely contribute to the ventral interneuron populations, and to a
much lesser extent to motoneurons. This ﬁnding was veriﬁed by co-
labeling GFP from the Z/EG locus with homeodomain factors Hb9,
Isl1/2, Lhx1/5, and Lhx3. As suspected, Neurog1 lineage cells have
broad overlap with the interneuron marker Lhx1/5 (Fig. 5G; yellow
IN), while only a small subset overlapped with the motoneuron
markers Hb9 and Isl1/2 (Fig. 5G–I). To determine if the Neurog1
lineage motoneurons belonged to a speciﬁc motoneuron pool, we
compared the overlap of GFP with Lhx3 and Isl1/2. A small subset of
Lhx3+ cells in theMMCm (Fig. 5I,I″) and a small subset of Isl1/2 in the
LMCl (Fig. 5I,I′) co-localize with GFP. However, GFP did not co-localize
with Isl1/2 in the LMCm. Thus, only a subset of motoneurons is
derived from theNeurog1 lineage, and evenwithin this subset, there is
a bias towards speciﬁc neuronal subtypes.Discussion
Cis-regulation of Neurog1 expression
We demonstrate that cis-regulatory regions for Neurog1 are
contained within 208 kb ﬂanking the coding region of Neurog1 with
the N1457-nGFP transgenic mice reliably reporting domains of Neurog1
expression throughout development. Neurog1 is expressed in
neuronal progenitor cells in many different regions throughout the
central and peripheral nervous systems in a pattern largely non-
overlapping to another bHLH factor Ascl1 (Ma et al., 1997; Sommer
et al., 1996). As such, the temporal and spatial control of Neurog1
expression is complex and includes multiple discrete regulatory
regions spread over more than 20 kb surrounding the coding exon.
Over the past decade, work in zebraﬁsh and mouse has identiﬁed
multiple cis-regulatory sequences for Neurog1 using sufﬁciency assays
in transgenic animals (Blader et al., 2004, 2003; Gowan et al., 2001;
Murray et al., 2000; Nakada et al., 2004). Here, using BAC transgenic
mice to test the requirement of these sequences in directing neural
speciﬁc expression in vivo, we ﬁnd additional complexities including
an apparent redundancy in enhancer activity, new activities for a
previously deﬁned enhancer, and localization of an enhancer for
ventral neural tube expression. The current understanding of how
Neurog1 is regulated is summarized below.
Studies in zebraﬁsh uncovered three enhancers within an 8.4 kb 5′
proximal genomic region, LSE, ANPE, and LATE, which are conserved
to mouse and have distinct activities when assayed as reporter
transgenes in vivo (for review see Strahle and Rastegar, 2008). The
LSE directs expression to the lateral stripes of the neural plate during
primary neurogenesis in cells that give rise to the Rohan Beard
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In contrast, the ANPE directs expression to the anterior neural plate,
and the LATE directs expression after completion of primary
neurogenesis to the neural tube, hindbrain, and diencephalon.
When tested in mouse the zebraﬁsh LATE also had activity in the
lateral telencephalon. None of these enhancers were reported to
direct expression to the dorsal root ganglia or to the motor neuron
domain in the ventral neural tube—two other areas of neurogenin 1
expression, although this information is within the 8.4 kb 5′ genomic
region tested.
Early studies on Neurog1 regulation in mouse showed that the
proximal 4.5 kb 5′ of Neurog1 was inefﬁcient at directing expression
to Neurog1 domains in transgenic mice (Gowan et al., 2001; Murray
et al., 2000). This proximal 5′ region was also recently reported to
undergo chromatin remodeling during activation of Neurog1 in retinoic
acid induced differentiation of P19 cells (Wu et al., 2009). In contrast, a
more efﬁcient regulatory region found further 5′ (TgN1-2) that contains
sequence conserved to the zebraﬁsh LSE, ANPE, and LATE could direct
expression of reporter transgenes efﬁciently to both dorsal and ventral
neural tube, more anterior domains in the hindbrain and midbrain,
some cranial sensory ganglia, and the olfactory epithelium. Notably,
enhancer activity for directing expression to the telencephalon and
dorsal root gangliawas absent (Gowan et al., 2001). A subsequent study
further delineated a 0.8 kb region that includes homology to the
zebraﬁsh LATE element that directs expression speciﬁcally to the dorsal
neural tube (here called TgN1-13dnt) (Nakada et al., 2004). In the
current study,we delineate another enhancer, distinct fromany of those
described above, that is sufﬁcient to direct expression toNeurog1 cells in
the ventral neural tube. The ventral neural tube enhancer has less
conservation between species than sequence for the other enhancers
since it is restricted tomammals. Taking these studies together, it is clear
that there is a cassette-like organization of discrete regulatory regions
that works together to direct the diverse pattern of Neurog1-speciﬁc
expression.
The regulatory regions identiﬁed to date are only part of the story,
since we cannot recapitulate the full Neurog1 pattern without using a
large genomic region as tested in the BAC. One promising approach in
the literature is to identify tissue speciﬁc enhancers using ChIP-Seq to
localize co-activators such as p300 (Visel et al., 2009). Since Visel et al.
used E11.5 forebrain and midbrain, tissues where Neurog1 is actively
expressed, we examined the published data set for p300 occupied
sites within the 208 kb in the BAC RP23 457E22. With forebrain tissue
there was a p300 binding region about 40 kb 3′ of Neurog1 (chr13:
56,309,425–56,310,401), a region not speciﬁcally tested in the
transgenic mice here. In contrast, p300 in midbrain tissue occupies a
region (chr13: 56,359,200–56,359,676) that is included within the
identiﬁed dorsal neural tube enhancer tested in TgN1-13dnt, a region
with homology to zebraﬁsh. Paradoxically, TgN1-13dnt alone did not
show activity in the midbrain suggesting other sequences and
complexes lacking p300 are required for efﬁcient expression in
midbrain. So while the use of ChIP-Seq with co-activators like p300 to
identify tissue speciﬁc enhancers is powerful in identifying some
important enhancer regions, using the current technology it is
unlikely to identify all enhancers.
The studies described above deﬁne activity of regulatory
sequences by determining whether they are sufﬁcient to direct
reporter gene expression to a particular tissue. In the current studywe
asked whether the identiﬁed enhancers are required for expression in
particular tissues. We predicted that deletion of sequence that
includes the dnt element as well as homology to the ANPE from the
208 kb Neurog1 BAC transgene would have lost GFP expression in the
dnt but not lose expression in other tissues like dorsal root ganglia.
Unexpectedly we found a uniform attenuation of enhancer activity in
all domains. This suggests the sequence deleted, while not sufﬁcient
to direct expression to all Neurog1 domains (see TgN1-2), is required
generally for expression of the locus (see N1457-nGFPΔR2). Further-more, deletion of this region revealed the existence of a weaker tissue
speciﬁc secondary enhancerwithin the 208 kb BAC since the complete
Neurog1 pattern was detected but just at much lower levels. The
existence of secondary enhancers in developmental genes has
recently been reported and is suggested to be an important
mechanism driving animal diversity (Hong et al., 2008; Jeong et al.,
2006; Markstein et al., 2002; Zeitlinger et al., 2007). Indeed, a recent
study tested the requirement for ultraconserved elements by knock-
ing them out in the mouse genome (Ahituv et al., 2007). Of the four
elements tested, none resulted in notable abnormalities in expression
of the locus or in negative consequences for viability. It remains to be
determined if the decrease in expression resulting from deletion of R2
or R3 (Fig. 2) would be sufﬁcient to disrupt nervous system
development.
There has been little advance in identifying factors that regulate
through the Neurog1 enhancers. Pax6 is a good candidate for an
upstream regulator since its expression in the telencephalon and
neural tube in mouse overlaps that of Neurog1. Indeed, Pax6 can bind
zebraﬁsh LATE in vitro, and LATE transgene activity in mouse
telencephalon and zebraﬁsh diencephalon requires Pax6 (Blader
et al., 2004). However, the sequence in themouseNeurog1 gene that is
conserved with zebraﬁsh LATE does not have activity in mouse
telencephalon, but rather is restricted to directing expression to the
dorsal neural tube (TgN1-13dnt) where Pax6 is not present. Thus,
although we cannot rule out a role for Pax6 in regulating mouse
Neurog1, it does not appear to be functioning through the same
enhancer in zebraﬁsh and mice, nor does there appear to be a Pax6
site within the newly localized ventral neural tube enhancer. Gli
factors are also candidates for regulating Neurog1 expression,
particularly in the ventral neural tube since they are downstream
effectors of Shh signaling and are active in patterning the ventral
neural tube (Vokes et al., 2007). Mutating two gli consensus sites
within the ventral neural tube enhancer appeared to attenuate
enhancer activity, although the overall pattern of expression
remained. Identifying the full complement of upstream signaling
events and transcription factors that regulate through the distinct
Neurog1 enhancers remains an area where little is known.
Neurog1 lineage in the developing spinal cord
The bHLH proteins such as Neurog1 act in balance with the Notch
pathway to control the timing of differentiation of neural progenitors
(Bertrand et al., 2002; Lee and Pfaff, 2001). In addition, in combination
with homeodomain factors, bHLH factors deﬁne distinct progenitor
cells in the developing spinal cord, and act to confer diversity to the
emerging nervous system (Bertrand et al., 2002; Briscoe et al., 2000;
Helms and Johnson, 2003; Shirasaki and Pfaff, 2002). Deﬁning the fate
of Neurog1 progenitor cells in the ventral spinal cord has been
complicated by multiple factors including (1) its transient expression
in progenitor cells, (2) its broad expression in ventral progenitor
domains, and (3) presumptive redundancy with the closely related
Neurog2 making phenotypic analysis of mutants more difﬁcult. In
particular, although Neurog1mutants have defects in proximal cranial
ganglia, olfactory neurons, and inner ear (Cau et al., 2002; Ma et al.,
2000, 1998), defects in other neural regions such as dorsal root
ganglia, spinal cord, and dorsal telencephalon require Neurog1/
Neurog2 double mutants to detect a phenotype (Fode et al., 2000;
Gowan et al., 2001; Ma et al., 1999; Scardigli et al., 2001). Our data
using in vivo genetic fate mapping places Neurog1 preferentially in
progenitors to interneurons including dI2, dI6, V0, V1, and V2, with a
minor contribution to motoneurons. Although Neurog1 is present in
these progenitor cells, no obvious phenotype has been seen in the
ventral spinal cord in Neurog1 mutant mice (Scardigli et al., 2001)
(HIQ and JEJ, unpublished data) possibly due to compensation by
Neurog2. In contrast, although Neurog1 can compensate for the loss of
Neurog2 in the initiation of neurogenesis, it does not compensate for
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motoneuron development (Scardigli et al., 2001).
Neurog1 functions in many regions of the developing nervous
system. In the CNS, its two accepted roles include (1) a general role in
initiating neuronal differentiation while suppressing glial lineages,
and (2) its particular role in specifying glutamatergic type neurons.
We note that Neurog1 lineage cells are almost exclusively neurons,
consistent with its function in neurogenesis (HIQ and JEJ, unpublished
data). In contrast, with respect to the second role of Neurog1, it is
worth noting that it is not restricted to glutamatergic neuronal
lineages. For example, using the same N1457-Cre transgenic line
reported here, it was recently shown that in the cerebellum the
Neurog1 lineage maps to a subset of Purkinje cells which are
GABAergic (Lundell et al., 2009). Future studies using these mice
will aid in identifying the full complement of Neurog1 derived cell
types in the animal.
With this study we extended our understanding of the complex
transcriptional mechanisms that have evolved to direct the precise
temporal and spatial expression of Neurog1, and deﬁned the cell types
within the neural tube that belong to the Neurog1 lineage. Our
understanding of these mechanisms is far from complete, particularly
with respect to identifying the upstream factors functioning through
the identiﬁed enhancers. Controlling the precise levels, timing, and
pattern of Neurog1 expression is critical for generating a normal
nervous system as its function is necessary for generating the correct
numbers and diversity of neurons required for the accurate assembly
of neuronal circuits.
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